BARROW ROBERT (Chief Executive Officer) sold 1.4% of their position (31.55K shares) of DEFINIUM THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.15M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/30/2026ACC: 0001104659-26-112062
DirectorOfficer· Chief Executive Officer
Since Jan 2022
-31.55K
Net shares
Net seller
$1.15M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
31.55K disposed
Non-Derivative Transactions1
Common Shares
Direct
Shares
−31.55K
Price / share
$36.57
Trade value
$1.15M
% of position
1.4%
9/25/2026
2.24M→2.21M
Total
Net shares
−31.55K
Net value
-$1.15M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 9/25/2026 | S · Sale | −31.55K | $36.57 | $1.15M | 1.4% | 2.24M | 2.21M |
| Total | −31.55K | -$1.15M | ||||||
Derivative Transactions0
No derivative transactions reported